Clinical Trial Update: A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706 [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating the potential drug–drug interaction between YHR1705 and YHR1706 has completed; sponsored by Yuhan Corporation, the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• YHR1705
• YHR1706

Snippet

Sponsor: Yuhan Corporation | Conditions: Dyslipidemia, Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED